|
1
|
New
Developments in the Pathobiology of Prostate Disease |
J.
Schalken (NL). |
|
2
|
Advances
in Biomarkers for Prostate Disease |
R.
Getzenberg (USA) |
|
3
|
Epidemiology
and Natural History of Prostate Disease |
M.
Barry (USA) |
|
4
|
New
Development in Imaging of the Prostate and Metastatic Sites |
M.
Resnick (USA) |
|
5
|
LUTS:
Etiology and Patient Assessment
|
P.
Abrams (UK)
|
|
6
|
New
Medical Developments in the Management of LUTS in Adult Men |
C.
Chapple (UK) |
|
7
|
New
Minimally-Invasive and Surgical Developments in the management of BPO
|
J.
de la Rosette (NL) |
|
8
|
Prevention
of BPH Outcomes and Clinical Progression |
C.
Roehrborn (USA) |
|
9
|
New
Therapeutic Targets in BPH and LUTS (Research Priorities) |
K-E.
Andersson (E) |
|
10
|
New
Developments in Screening and early Detection for Prostate Cancer |
F.
Schroeder (NL) |
| 11 |
Prostate
Cancer Chemoprevention |
P.
Gan (USA) |
| 12 |
New
Developments in the Treatment of Localized Prostate Cancer |
F.
Schroeder (NL) |
| 13 |
New
Therapeutic Targets and Treatments for Metastatic Prostate Cancer |
W.
Nelson (USA) |
| 14 |
Androgen
Replacement Therapy in Men at Risk for Prostate Disease |
C.L
Schulman (Belgium) |
| 15 |
Prostatitis
and Chronic Pelvic Pain |
T.
Schaeffer (USA) |
| 16 |
Patient’s
Perspectives in Prostate Diseases |
T.
Hudson (E) |
| |
History
of Prostatic Diseases |
D.
Schultheiss-R. Waldbaum |
